Variations in prostate carcinoma practice patterns and outcomes exist. The completion of randomized trials is required to determine the preferred strategy for the detection and treatment of localized prostate carcinoma. Implementation of results from completed randomized trials would enhance the delivery of evidence-based androgen suppression therapy for patients with advanced prostate carcinoma.
|Original language||English (US)|
|Number of pages||5|
|State||Published - Mar 15 2000|